Ultrasound Guided Ulnar Versus Radial Artery in Pediatrics Undergoing Major Non Cardiac Surgery

March 3, 2024 updated by: Khaled Abdelfattah Abdallah Sarhan, Kasr El Aini Hospital

Ultrasound Guided Ulnar Versus Radial Artery Cannulation in Pediatrics Undergoing Major Non Cardiac Surgery: Double Blinded Randomized Controlled Study

This study aims to assess the safety and efficacy of ulnar artery cannulation compared to radial artery cannulation in pediatrics undergoing major non cardiac procedures.

Study Overview

Detailed Description

The study is a double blinded randomized controlled trial that will be conducted at Abu Al Reesh Children's Hospital, Faculty of Medicine, Cairo University after approval of research and ethics committees.

Children will be recruited into the trial during pre-operative assessment. will be randomly assigned to one of two groups Recruited patients will be randomly allocated by a computer-generated sequence of codes using randomization software (https://www. randomizer.org) into one of the two groups; in a 1:1 ratio (Group R) to receive radial artery cannulation and (Group U) to receive ulnar artery cannulation using ultrasound. The randomization sequence will be concealed in sequentially numbered, sealed opaque envelopes. The sealed envelopes will be opened by an anesthesia nurse immediately before induction of anesthesia.

After induction of anesthesia, modified Allen's test will be done by the ultrasound operator as following:

An Esmarch bandage will be used to exsanguinate the selected hand for cannulation according to the operator preference for 30 seconds, then the operator will apply simultaneous pressure to the ulnar and radial arteries of the chosen limb to occlude them. The bandage will then be released. Next, the pressure over the opposed artery selected for cannulation will be released and the time (in seconds) it takes for color to return to the hand will be measured.

Allen test results will be interpreted as follows:

If color returns to the hand within 5 seconds, the result of the Allen test is negative (normal) and the artery can safely be cannulated.

If color does not return to the palm within 5 seconds, the test result is positive (abnormal). The test will be repeated on the other hand and if the test is positive another site will be selected for cannulation, and the patient will be excluded from the study.

The patient's wrist will be extended over a roll to keep the angle of the wrist unchanged to 30- 45 degrees. After hand washing and sterile gloving; skin will be prepared using alcohol-based chlorhexidine antiseptic in both groups.

Assessment of proposed artery for cannulation using ultrasonography will be performed by one of 2 pediatric anesthesiologists blinded to group allocation who have performed more than 50 ultrasound guided arterial cannulation in pediatrics.

Ultrasound examination will be performed using a hockey stick, high frequency (5-10 MHz) ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA).

Image depth will be set to 2- 3 cm and gain settings adjusted to enhance views. Both external force and the angle will be manipulated to optimize images.

The radial artery will be identified in the transverse plane and confirmed with color flow doppler, then in the longitudinal plane by rotating the probe 90 degrees clockwise while maintaining the arterial image. This method will be repeated for the ulnar artery. All antro-posterior (AP) and transverse (T) diameters will be made at the inner (intimal) edge of the vessel. AP diameter will be measured on both transverse and longitudinal images. Cross-sectional area (CSA) will be calculated then as following: π [AP × T] /4. Three measurements will be collected, and the average values will be used for analysis.

Arterial cannulation will be performed using the long axis view (in-plane) technique with a 24 or 22-gauge canulae (Euromed For Medical Industries, S.A.E., Cairo, Egypt) according to the operator preference. Cannulation will be considered complete when the arterial waveform is confirmed on the monitor. If cannulation is unsuccessful within the third attempt or within 10 min, the case will be considered a failure at the chosen artery. After the failure, an alternative site will be used for cannulation and the case will be excluded from the study. The overall procedure time of arterial cannulation is defined as the time interval from the first skin puncture by the canula to confirmation of the arterial waveform on the monitor. After the procedure, the diameter of the cannulated artery and the occurrence of hematoma or vasospasm will be evaluated with ultrasound. Data will be collected by another anesthesiologist who is blinded to the group allocation.

Study Type

Interventional

Enrollment (Actual)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11559
        • Cairo university hospitals, kasralainy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 10 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

- All pediatrics ASA I&II aged 1 month -10 years undergoing major non cardiac surgeries.

Exclusion Criteria:

  • • Patients undergoing cardiac surgeries.

    • Refusal of parents.
    • Ischemia defined as (color changes: blanching, duskiness, and or change in temperature of the extremity used for cannulation compared to the contralateral one).
    • Previous arterial cannulation within last week.
    • Patients requiring inotropic support before the start of procedures.
    • Rash or signs of infection or hematoma at the site of cannulation.
    • Patients requiring emergency procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: (Group R)
receive radial artery cannulation using ultrasound

Ultrasound examination will be performed using a hockey stick, high frequency (5-10 MHz) ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA).

. Arterial cannulation will be performed using the long axis view (in-plane) technique with a 24 or 22-gauge canulae according to the operator preference. Cannulation will be considered complete when the arterial waveform is confirmed on the monitor. If cannulation is unsuccessful within the third attempt or within 10 min, the case will be considered a failure at the chosen artery. After the failure, an alternative site will be used for cannulation and the case will be excluded from the study.

Active Comparator: (Group U)
receive ulnar artery cannulation using ultrasound

Ultrasound examination will be performed using a hockey stick, high frequency (5-10 MHz) ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA).

. Arterial cannulation will be performed using the long axis view (in-plane) technique with a 24 or 22-gauge canulae according to the operator preference. Cannulation will be considered complete when the arterial waveform is confirmed on the monitor. If cannulation is unsuccessful within the third attempt or within 10 min, the case will be considered a failure at the chosen artery. After the failure, an alternative site will be used for cannulation and the case will be excluded from the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of successful cannulation at first attempt
Time Frame: 15 minutes
(the procedure will be classified as successful when the artery is cannulated, and an arterial waveform is recorded within less than 3 attempts and or 15 minutes from the first puncture).
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diameters of the arteries before cannulation
Time Frame: preoperative
Anteroposterior, transverse diameters and cross-sectional area of the arteries before cannulation
preoperative
diameters of the arteries after cannulation
Time Frame: 15 minutes from start of cannulation
Anteroposterior, transverse diameters and cross-sectional area of the arteries after cannulation
15 minutes from start of cannulation
incidence of vasospasm
Time Frame: 15 minutes from start of cannulation
more than 25% decrease in the artery diameter after cannulation without intra-arterial hematoma.
15 minutes from start of cannulation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 5, 2023

Primary Completion (Actual)

October 1, 2023

Study Completion (Actual)

October 1, 2023

Study Registration Dates

First Submitted

March 5, 2023

First Submitted That Met QC Criteria

March 5, 2023

First Posted (Actual)

March 16, 2023

Study Record Updates

Last Update Posted (Estimated)

March 5, 2024

Last Update Submitted That Met QC Criteria

March 3, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • MS-225-2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on ultrasound guided radial versus ulnar artery cannulation

Subscribe